Neena Brizmohun's profile photo

Neena Brizmohun

London

Deputy Editor at The Pink Sheet

Deputy Editor at Medtech Insight

Deputy Editor at Scrip

Deputy editor of Pink Sheet/Scrip/Medtech Insight. Interested in science, pharma and medtech. All views expressed are my own.

Featured in: Favicon informa.com (+5) Favicon pharmamedtechbi.com Favicon chemistanddruggist.co.uk Favicon citeline.com (+1)

Articles

  • Safety Review Prompts EMA to Suspend Ixchiq Chikungunya Vaccine For Seniors

    1 week ago | insights.citeline.com | Neena Brizmohun

    Safety Review Prompts EMA to Suspend Ixchiq Chikungunya Vaccine For SeniorsThe European Medicines Agency is investigating whether Valneva’s Ixchiq is safe to use in the elderly, following reports of 17 serious adverse events, including two cases resulting in death, in people aged 62 to 89 years who received the vaccine. This follows actions by US and French authorities last month regarding Ixchiq’s use in people over 65.

  • Unlocking Opportunities: How To Engage With The EMA On Animal Testing Alternatives

    1 week ago | insights.citeline.com | Neena Brizmohun

    Unlocking Opportunities: How To Engage With The EMA On Animal Testing Alternatives The European Medicines Agency, like its counterpart in the US, is increasingly focusing on the use of alternatives to animal testing. Alternatives to animal tests being explored include organ-on-a-chip models (Shutterstock)

  • New Guidance From Canada’s HTA Agency On Submission Of AI-Driven Evidence

    2 weeks ago | insights.citeline.com | Neena Brizmohun

    New Guidance From Canada’s HTA Agency On Submission Of AI-Driven EvidenceRecognizing that the evidence it receives in applications for health technology assessments will increasingly be informed by artificial intelligence, the CDA-AMC has clarified its expectations for companies that use AI methods in the generation and/or reporting of evidence.

  • Canada’s HTA Agency Reveals How To Submit AI-Driven Evidence

    2 weeks ago | insights.citeline.com | Neena Brizmohun

    Canada’s HTA Agency Reveals How To Submit AI-Driven Evidence Recognizing that the evidence it receives in applications for health technology assessments will increasingly be informed by artificial intelligence, the CDA-AMC has clarified its expectations for companies that use AI methods in the generation and/or reporting of evidence. AI can be used to generate evidence used in applications for health technology assessments (Shutterstock)

  • New EU Filings

    2 weeks ago | insights.citeline.com | Neena Brizmohun

    New EU FilingsPlozasiran, Arrowhead Pharmaceuticals' treatment for familial chylomicronemia syndrome, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
928
Tweets
963
DMs Open
No
Neena Brizmohun
Neena Brizmohun @ScripRegNeena
12 Oct 22

We’re really excited for tomorrow’s webinar on useful tactics for streamlining pharmacovigilance and medical information processes in today's regulatory landscape. Follow the link for more information and to register your attendance https://t.co/QmznXZRXU7

Neena Brizmohun
Neena Brizmohun @ScripRegNeena
28 Mar 22

RT @ScripRegVibha: Looking forward to the DIA Europe 2022 meeting tomorrow. Some great sessions listed on the agenda, especially on EU Clin…

Neena Brizmohun
Neena Brizmohun @ScripRegNeena
11 Feb 22

RT @ScripRegMaureen: This free-to-view article from @PharmaPinkSheet sister publication @Genericbulletin highlights the off-patent industry…